Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-09-07-Speech-3-124"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20050907.15.3-124"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
"This report contravenes a very important principle of EU cooperation, namely the country of origin principle. It proposes that an EU paediatric authority be set up to assess, approve and monitor paediatric medicines and encourage their production. There are, however, no good reasons for centralising this activity in a new EU authority.
The report is also based on the notion that the pharmaceutical industry does not think it profitable to develop special paediatric medicines. That is not very convincing. If there is demand, there is also supply. If there is anything that companies in a market economy are good at, it is identifying niches and manufacturing products for them. If it is true that there is a great need for special paediatric medicines, the solution should be sought on the demand side through the authorities in the individual countries.
The whole report is permeated by efforts to extend the EU’s influence and develop new bureaucracies.
For these reasons, we have voted against the report."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples